The definition and risks of Cytokine Release Syndrome-Like in 11 COVID-19-Infected Pneumonia critically ill patients: Disease Characteristics and Retrospective Analysis

Study design and participants

This was a retrospective single-center study. The patients enrolled in this study were confirmed to have severe or critical COVID-19-infected pneumonia patients. The inclusion criteria were “Pneumonia diagnosis and treatment plan for new coronavirus infection (trial version 5)” issued by the National Health Commission on February 5, 2020 (hereinafter referred to as “Diagnosis and treatment plan version 5”) [7]. Enrollment began on January 26, 2020. We obtained verbal consent from each patient. According to the monitoring results (the date of transfer out of the ICU), the final follow-up date was February 18, 2020 for all COVID-19-infected patients participating in this study. This series of cases was approved by the ethics committee of the First Affiliated Hospital of Guangzhou Medical University.

Data collection

The team of the First Affiliated Hospital of Guangzhou Medical University analysis of the patient’s medical records included:

1. Basic information of the patient: name, gender, age, hospitalization number, diagnosis, date of admission, condition, laboratory examination results, chest CT scan, nursing care, and treatments (i.e. antiviral treatment, corticosteroid treatment, and respiratory support. The records were taken by a team of trained doctors, and the data were obtained from electronic medical records.

2. Data generated by bedside monitor: heart rate, respiration, invasive / non-invasive blood pressure, blood oxygen saturation, hemodynamic monitoring.

3. Medical order execution information: administration times for all medicines, drug name, dose, concentration, route, automatically generated in and out quantity. These data were automatically collected by the ICU clinical information system.

Acute respiratory distress syndrome (ARDS) and shock are based on the World Health Organization Interim guidelines for the novel coronavirus. Hypoxemia was defined as PaO₂/ FiO₂ below 300 mm Hg. (PaO₂ means arterial oxygen tension; FiO₂ means inhaled oxygen fraction). Acute renal injury was determined and classified according to the highest serum creatinine level or urination standard and classified according to the global results of kidney disease improvement. If the patient had clinical symptoms or signs of nosocomial pneumonia or bacteremia, it was diagnosed as a secondary infection and combined with positive culture of new pathogens from lower respiratory tract samples (including sputum, tracheal intubation suction fluid, bronchoalveolar lavage fluid, or blood samples ≥ 48 hours after admission). If the serum level of cardiac biomarkers (such as cardiac troponin I) was higher than the 99% reference upper limit, or the ECG and echocardiography showed new abnormalities, the patient was diagnosed with cardiac injury.

RT-PCR Assay for COVID-19

RT-PCR was performed with a Bio-RadCFX96 Real-Time PCR System, and 20 μL reaction volumes contained 10□μL of RNA, 5□μL ORF1ab/N primer provided with a COVID-19 kit (HuiruiBio, Shanghai,China), 1 detection reaction power with one step RT-PCR Master Mix Reagents from the kit, and 5□μL RNase Free H₂O (TiangenBio, Beijing, China). Thermal cycling was performed at 55°C for 15 minutes for reverse transcription, followed by 95°C for 5 minutes, 45 cycles of 95°C for 10 seconds, and then 55°C for 40 seconds. Fluorescence was recorded during the 55°C phase. The results of the RT-PCR were valued by threshold cycle (CT). When CT>39.2, the sample was negative; when CT<35, the sample was positive; when 35<CT<39.2, the sample was retested.

Flow cytometry analysis

EDTA anticoagulation venous blood samples (2 mL) were collected from each of the 2019-nCoV patients. Peripheral blood mononuclear cells (PBMCs) were isolated using density-gradient Ficoll-Paque Plus (Amersham Biosciences, Little Chalfont, United Kingdom) centrifugation. Duplicate PBMCs (10⁶ cells/tube) were stained with CD3-FITC/CD56+16-PE/CD45-PerCP-CY5.5/CD4-PC7/CD19-APC/CD8-APC -CY7/CD25-APC/CD127-PE (Tongsheng Shidai Biote Co. LTD, Beijing, China) in the dark at room temperature for 30□minutes. The cells were then fixed and permeabilized using a permeabilization solution (BD Biosciences, New Jersey, USA). The mononuclear cells were gated using cell size and internal structure in a FACS Aria II (Novo Cyte D3000, Agilent Technologies Inc., Palo Alto, California, USA). The frequency of various subsets of T cells was determined using FlowJo software (v10; TreeStar, Ashland, OR, USA). The number of different subsets of T cells was calculated and expressed as the number of cells per L for each subject.

Patient and public involvement

This was a retrospective case series study and no patients were involved in the study design, setting the research questions, or the outcome measures directly. No patients were asked to advise on interpretation or writing up of results.

1. Clinical Characteristics and laboratory examination

All 11 COVID-19-infected critically ill pneumonia patients were admitted to the ICU. 10 (90.9%) of them were males. The median age was 58 years (IQR, 49-72 years). The median time from first symptoms to respiratory distress was 10 d (IQR, 7-13 days). All patients had fever, and the highest fever was 40°C, and the median fever temperature was 38.5°C (IQR, 38-39.6°C). Four (36.4%) patients had muscle soreness in the early stage of fever, and 9 (81.8%) had dry cough in the early stage. All patients had symptoms of hypoxia when they were admitted to ICU. Among them, 5(45.5%)patients had a history of Cardio-cerebrovascular disease, and 4(36.4%) patients had a history of diabetes (type II diabetes). All the patients had symptoms of low oxygen saturation and metabolic acidosis (Table 1). After entering the ICU, all the patients had at least one or more organ dysfunction or even failure manifestations. These included 9 patients with cardiac dysfunction, 8 with renal dysfunction, 6 with liver dysfunction and coagulation dysfunction, 5 with coagulant function abnormality, and 4 with multi-organ failure syndrome. 10 patients were treated with steroids and all patients had antiviral and anti-infective therapy (Table 2 and Table 3).

2. Immunological parameters analysis

Flow cytometry was used to detect the peripheral blood monocytes, including: CD3 (CD3 + CD45+), CD4 (CD3 + CD4+), CD8 (CD3 + CD8+), NK (CD3-CD16 + CD56 +), Tregs (CD4 + CD25 + CD127 low), and b-lymphocyte (CD3-CD45 +). In the first day being admitted to the ICU, the absolute counts of CD3, CD4, CD8, and NK in the peripheral blood were lower than the normal value: CD3 (IQR,169-355; range, 50–635 cells/μL), CD4 (IQR,101–308; range, 27–350 cells/μL), CD8 (IQR, 33-141; range, 21–277 cells/μL), NK immune cells (IQR,8-72; range, 5-170 cells/μl). Eight patients had a significant increase of the CD4/CD8 ratio (IQR, 1.05-7.7), which is an important index in autoimmune diseases (systemic lupus erythematosus, type I diabetes, and rheumatoid arthritis) and transplant rejection (16) (Table 3). Three had a decrease in B-lymphocytes, and two patients had a slight increase in Tregs (sFigure 1). After treatment, the CD4 in two patients and CD8 in three patients were increase to normal levels. In addition, IL-2, IL-4, IL-6, IL-10, TNF - α, and IFN - γ were detected in all of the patients. IL-6 was significantly increased in all of the patients (IQR, 14.26-99.2; range, 4.58–1182.91ng/L) (Table 3). The level of IL-10 was increased in five patients, while IL-4 and IFN - γ were increased in three and two patients, respectively. After treatment, IL-6 in three patients, IL-10 in four patients and IL-4, IFN - γ in all patients were returned to normal levels (sFigure 1).

3. Identification of CRSL in COVID-19-Infected Critically ill pneumonia patients

The main characteristics of CRS include a decrease of T cells and NK cells, an increase of IL-6, fever, organ and tissue dysfunction, and an abnormal coagulation function (20). All of the 11 ICU patients had pulmonary infection and fever. All had a significant decrease of circulating T cells, NK cells, and an increase of IL-6 secretion in peripheral blood. In addition, all the patients had one or more organ dysfunctions or failure, and seven patients had coagulation dysfunction. Eight patients showed a significant increase in the ratio of CD4/CD8, suggesting the possibility of an autoimmune response (Table 3 and Table 4). None of the patients had a known prior history of immune diseases. IL-6 level in three of these patients recovered to normal after infection treatment, and CT results shown the pulmonary shadows were disappeared. At the meantime, this three patients without evidence of extrapulmonary organ injury, and blood coagulation dysfunction, and two of them have been transferred out of ICU. There were eight of the 11 patients showed sufficient evidence in CRS features (Table 3 and Figure 1). After treatment, CD4, CD8, and NK cells were all recovered. In addition, IL-6 and IFN - γ were also decreased. At the same time, the organ function of the patients improved (Table 3 and sFigure 1).

• Download figure
• Open in new tab

Figure 1. Timeline of disease course according to days from definite diagnosis of illness and days from Enter ICU.

Before entering the ICU, nine people received corticosteroid therapy. In the treatment and nursing process of ICU, six patients were intubated, two patients were ECMO, and eight patients had CRS-like symptoms, two patients who had non-CRS-like symptoms were transferred out of ICU.

3. IL-6 was a sensitive indicator for the outcome of COVID-19 pneumonia with CRSL

All 11 patients were admitted to the ICU because of fever and ARDS. Among them, three patients received noninvasive ventilation, eight patients received invasive ventilation (including two ECMO treatment). Four people used medicine to cool down, 7 cases used physical hypothermy (ice compress). All of the patients were COVID-19 positive and received antiviral or anti-infective treatment, while nine received hormone treatment. During the treatment period, 9 patients had peripheral CD3, 9 patients had CD4, 8 patients had CD8, and 8 patients had NK cells increased, while seven patients had a decrease in CD3 / CD8 (Table 4 and Figure 2A). However, there were 3 patients (patient 02#, 03# and 07#) who with stable condition after ICU at the beginning, the IL-6 levels were rapid increase (increased 7.2 to 9.2 times) in one or two days(Figure 2B); the absolution number of CD4 and CD8 were decrease one day later than the increase of IL-6 in peripheral blood (Figure 2C and 2D). The PaO₂ and PaO₂/FiO₂ were decrease within the next day after the rose of IL-6 (Figure 2E and 2F). At the meantime, the bedside chest radiograph results shown the disease progression (Figure 2G). This cases indicated IL-6 was a early indicators of CRSL in COVID-19-infected pneumonia.

• Download figure
• Open in new tab

Figure 2. The relationship of Immunologic detection and CRSL after COVID-19 infected.

A. The effect of effective treatment in ICU on immune cell subsets and cytokine IL6 Changes of immune cell subsets and cytokine IL-6 after effective treatment in ICU. The absolute counts of CD4+(P=0.013) and CD8+(P=0.048) cells were increased, while the inflammatory cytokines IL-6 (P=0.040) was decreased.

B-F. Dynamic analysis of IL-6 levels,CD3+CD4+, CD3+CD8+ absolute counts, PaO₂, and PaO₂/FiO₂ in 3 patients with severe pneumonia of covid-19.The absolute counts of CD3+CD4+ in patient#3, patient#2 and patient#7 at different dates during ICU (B-D). PaO₂ and the oxygenation index PaO₂ / FiO₂have been in a fluctuating level in different dates during ICU (E and F).

G. Chest x-rays of three COVID-19-infected pneumonia patients at indicated date.

4. The relationship of pulmonary inflammation and CRSL characteristics after COVID-19 infected

Serious pulmonary inflammation is a common symptom in critically ill COVID-19-infected pneumonia patients [13]. The large area of infection and inflammatory reaction will cause cytokine release syndrome (CRS)[14]. In our study, according to the patchy shadows or ground glass opacity distribution in the chest CT images, we were divided the patients into < 50% and ≥ 50% groups (Figure 3A). The numbers of CD4, CD8, and NK cells in the peripheral blood of were higher in the ≥ 50% groups than in ≥ 50% groups patients (Figure 3B, 3C and 3D). At the meantime, the level of IL-6 in peripheral blood was lower in the patients with the area of inflammatory ≥50 than in <50% in CT imaging (Figure 3E).

• Download figure
• Open in new tab

Figure 3. The relationship of pulmonary inflammation and CRSL characteristics after COVID-19 infected.

A. Computed tomography of the chest of patients with COVID-19. According to the patchy or ground glass shadows in the chest CT images, the patients were divided into < 50% and ≥ 50% groups.

B-E. The relationship between the shadow area of lung and the absolute count of CD3+CD4+, CD3 + CD8+, NK cells and the level of IL6 in plasma were compared. When the shadow area is less than 50%, the absolute counts of CD4 +(P=0.006), CD8 +(P=0.020), NK cells(P=0.016) is higher than the shadow area greater or equal to 50%. But the level of IL-6 (P=0.004) was in contrat.